The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Subscribe To Our Newsletter & Stay Updated
